UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 251

Sortiert nach

Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

Annals of oncology, 2018-10, Vol.29, p.viii367-viii368

2018

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.104-112

2018

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) in newly diagnosed patients (pts) with chronic phase chronic myelogenous leukemia (CP CML) treated with bosutinib (BOS) or imatinib (IM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6612-6612

2011

Volltextzugriff (PDF)

1033PEfficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Realization of systolic array design for earthquake detection

2017 International Conference on Computational Intelligence in Data Science(ICCIDS), 2017, p.1-6

2017

Volltextzugriff (PDF)

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Blood, 2019-06, Vol.133 (23), p.2465-2477

2019

Volltextzugriff (PDF)

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

Molecular psychiatry, 2014-03, Vol.19 (3), p.351-357

2014

Volltextzugriff (PDF)

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

PloS one, 2019-06, Vol.14 (6), p.e0215739-e0215739

2019

Volltextzugriff (PDF)

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

The New England journal of medicine, 2016-05, Vol.374 (21), p.2054-2064

2016

Volltextzugriff (PDF)

Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns

Clinical radiology, 2019-09, Vol.74 (9), p.737.e3-737.e15

2019

Volltextzugriff (PDF)

Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis

Pediatric rheumatology online journal, 2016-08, Vol.14 (1), p.47-47, Article 47

2016

Volltextzugriff (PDF)

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

Trials, 2021-10, Vol.22 (1), p.689-689, Article 689

2021

Volltextzugriff (PDF)

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Annals of the rheumatic diseases, 2016-03, Vol.75 (3), p.481-489

2016

Volltextzugriff (PDF)

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015

Archives of disease in childhood, 2019-07, Vol.104 (7), p.640

2019

Volltextzugriff (PDF)

Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

American journal of neuroradiology : AJNR, 2022-09, Vol.43 (9), p.E19-E35

2022

Volltextzugriff (PDF)

Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5674

2022

Volltextzugriff (PDF)

Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab

Indian pediatrics, 2020-07, Vol.57 (7), p.681-683

2020

Volltextzugriff (PDF)

Treatment strategies for Sjögren’s syndrome with childhood onset: a systematic review of the literature

Rheumatology (Oxford, England), 2022-03, Vol.61 (3), p.892-912

2022

Volltextzugriff (PDF)

Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups

Lupus, 2020-04, Vol.29 (5), p.474-481

2020

Volltextzugriff (PDF)

Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus

Rheumatology (Oxford, England), 2022-08, Vol.61 (8), p.3378-3389

2022

Volltextzugriff (PDF)

COVID-19 vasculitis and novel vasculitis mimics

The Lancet. Rheumatology, 2021-03, Vol.3 (3), p.e224-e233

2021

Volltextzugriff (PDF)

Management of JIA associated uveitis

Best practice & research. Clinical rheumatology, 2024-07, p.101979, Article 101979

2024

Volltextzugriff (PDF)

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment

Molecular psychiatry, 2013-07, Vol.18 (7), p.781-787

2013

Volltextzugriff (PDF)

Severe hepatotoxicity as a rare side effect of anakinra in a patient with systemic JIA

Rheumatology (Oxford, England), 2021-09, Vol.60 (9), p.e307-e308

2021

Volltextzugriff (PDF)

Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging

Rheumatology (Oxford, England), 2014-11, Vol.53 (11), p.1973-1976

2014

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(227)

Publikationsform

Sprache

Englisch
(250)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Health-related quality of life (HRQoL) in newly diagnosed patients (pts) with chronic phase chronic myelogenous leukemia (CP CML) treated with bosutinib (BOS) or imatinib (IM)

1033PEfficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

Realization of systolic array design for earthquake detection

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns

Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015

Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?

Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab

Treatment strategies for Sjögren’s syndrome with childhood onset: a systematic review of the literature

Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups

Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus

COVID-19 vasculitis and novel vasculitis mimics

Management of JIA associated uveitis

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment

Severe hepatotoxicity as a rare side effect of anakinra in a patient with systemic JIA

Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging

Suchergebnisse filtern